用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
HOFFMANN LA ROCHE [CH](8)
专利信息
Translation Company
查询条件
展开筛选条件
[专利权人] 包含 'HOFFMANN LA ROCHE [CH]'
[药品] 包含 'Trastuzumab'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
尾页
共
8
条记录, 当前第1/1页。
公开号
公开日
申请号
申请日
1.
EP2687202A1
2014/1/22
EP20130166031
2010/7/28
专利标题
:Subcutaneous anti-her2 antibody formulation
专利权人
:
HOFFMANN LA ROCHE [CH]
;
The present invention relates to a highly concentrated, stable pharmaceutical formulation of a pharmaceutically active anti-HER2 antibody, such as e.g. Trastuzumab (HERCEPIN ), Pertuzumab or T-DM1, or a mixture of such antibody molecules for subcutaneous injection. In particular, the present invention relates to formulations comprising, in addition to a suitable amount of the anti-HER2 antibody, an effective amount of at least one hyaluronidase enzyme as a combined formulation or for use in form...
2.
EP2648719A1
2013/10/16
EP20110796899
2011/12/7
专利标题
:TREATMENT OF HER2-POSITIVE CANCER WITH PACLITAXEL AND TRASTUZUMAB-MCC-DM1
专利权人
:
HOFFMANN LA ROCHE [CH]
;
3.
TW201328708A
2013/7/16
TW20130110768
2010/7/30
专利标题
:Subcutaneous anti-HER2 antibody formulation
专利权人
:
HOFFMANN LA ROCHE [CH]
;
The present invention relates to a highly concentrated, stable pharmaceutical formulation of a pharmaceutically active anti-HER2 antibody, such as e.g. Trastuzumab (HERCEPINTM), Pertuzumab or T-DM1, or a mixture of such antibody molecules for subcutaneous injection. In particular, the present invention relates to formulations comprising, in addition to a suitable amount of the anti-HER2 antibody, an effective amount of at least one hyaluronidase enzyme as a combined formulation or for use in for...
4.
MX2012012736A
2013/2/26
MX20120012736
2012/10/31
专利标题
:DIAGNOSTIC METHOD FOR THE DETECTION OF CELLS EX VIVO.
专利权人
:
HOFFMANN LA ROCHE [CH]
;
The present invention relates in essence to a method for detecting a subset of cells with a binding domain which is specific for a target which characterizes said subset of cells, which method comprises detecting, ex vivo, said subset of cells, wherein said binding domain is to be administered to a subject which comprises or is assumed to comprise said subset of cells, prior to the removal of said subset of cells. The present invention also relates to the use of a binding domain as defined herei...
5.
MX2012001124A
2012/3/29
MX20120001124
2012/1/26
专利标题
:SUBCUTANEOUS ANTI-HER2 ANTIBODY FORMULATION.
专利权人
:
HOFFMANN LA ROCHE [CH]
;
The present invention relates to a highly concentrated, stable pharmaceutical formulation of a pharmaceutically active anti-HER2 antibody, such as e.g. Trastuzumab (HERCEPINâ ), Pertuzumab or T-DM1, or a mixture of such antibody molecules for subcutaneous injection. In particular, the present invention relates to formulations comprising, in addition to a suitable amount of the anti-HER2 antibody, an effective amount of at least one hyaluronidase enzyme as a combined formulation or for use in for...
6.
CA2797741A1
2011/11/10
CA20112797741
2011/5/9
专利标题
:DIAGNOSTIC METHOD FOR THE DETECTION OF CELLS EX VIVO
专利权人
:
HOFFMANN LA ROCHE [CH]
;
The present invention relates in essence to a method for detecting a subset of cells with a binding domain which is specific for a target which characterizes said subset of cells, which method comprises detecting, ex vivo, said subset of cells, wherein said binding domain is to be administered to a subject which comprises or is assumed to comprise said subset of cells, prior to the removal of said subset of cells. The present invention also relates to the use of a binding domain as defined herei...
7.
TW201106973A
2011/3/1
TW20100125487
2010/7/30
专利标题
:Subcutaneous anti-HER2 antibody formulation
专利权人
:
HOFFMANN LA ROCHE [CH]
;
The present invention relates to a highly concentrated, stable pharmaceutical formulation of a pharmaceutically active anti-HER2 antibody, such as e.g. Trastuzumab (HERCEPINTM), Pertuzumab or T-DM1, or a mixture of such antibody molecules for subcutaneous injection. In particular, the present invention relates to formulations comprising, in addition to a suitable amount of the anti-HER2 antibody, an effective amount of at least one hyaluronidase enzyme as a combined formulation or for use in for...
8.
CA2768458A1
2011/2/3
CA20102768458
2010/7/28
专利标题
:SUBCUTANEOUS ANTI-HER2 ANTIBODY FORMULATION
专利权人
:
HOFFMANN LA ROCHE [CH]
;
The present invention relates to a highly concentrated, stable pharmaceutical formulation of a pharmaceutically active anti-HER2 antibody, such as e.g. Trastuzumab (HERCEPIN), Pertuzumab or T-DM1, or a mixture of such antibody molecules for subcutaneous injection. In particular, the present invention relates to formulations comprising, in addition to a suitable amount of the anti-HER2 antibody, an effective amount of at least one hyaluronidase enzyme as a combined formulation or for use in form ...
首页
1
尾页
共
8
条记录, 当前第1/1页。
当前查询条件: [专利权人] 包含 'HOFFMANN LA ROCHE [CH]'
AND
[药品] 包含 'Trastuzumab'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文